AU6285194A - Stabilised pharmaceutical compositions and methods for preparing same - Google Patents
Stabilised pharmaceutical compositions and methods for preparing sameInfo
- Publication number
- AU6285194A AU6285194A AU62851/94A AU6285194A AU6285194A AU 6285194 A AU6285194 A AU 6285194A AU 62851/94 A AU62851/94 A AU 62851/94A AU 6285194 A AU6285194 A AU 6285194A AU 6285194 A AU6285194 A AU 6285194A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- pharmaceutical compositions
- preparing same
- stabilised pharmaceutical
- stabilised
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9303060A FR2702660B1 (en) | 1993-03-17 | 1993-03-17 | Stabilized therapeutic compositions and process for their preparation. |
| FR9303060 | 1993-03-17 | ||
| PCT/FR1994/000296 WO1994021298A1 (en) | 1993-03-17 | 1994-03-17 | Stabilised pharmaceutical compositions and methods for preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6285194A true AU6285194A (en) | 1994-10-11 |
Family
ID=9445053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62851/94A Abandoned AU6285194A (en) | 1993-03-17 | 1994-03-17 | Stabilised pharmaceutical compositions and methods for preparing same |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0689457A1 (en) |
| CN (1) | CN1119414A (en) |
| AU (1) | AU6285194A (en) |
| CA (1) | CA2158140A1 (en) |
| FR (1) | FR2702660B1 (en) |
| WO (1) | WO1994021298A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2293100A (en) * | 1994-09-15 | 1996-03-20 | Medeva Europ Ltd | Pharmaceutical compositions with deuterium oxide |
| WO2003018614A1 (en) * | 2001-08-24 | 2003-03-06 | Wako Pure Chemical Industries, Ltd. | Method of stabilizing substance altering in aqueous medium |
| US8734525B2 (en) | 2003-12-31 | 2014-05-27 | Warsaw Orthopedic, Inc. | Osteoinductive demineralized cancellous bone |
| EP1701729B1 (en) | 2003-12-31 | 2018-05-02 | Warsaw Orthopedic, Inc. | Improved bone matrix compositions and methods |
| JP2007519496A (en) * | 2004-01-27 | 2007-07-19 | オステオテック，インコーポレイテッド | Stabilized bone graft |
| WO2007053850A2 (en) | 2005-11-01 | 2007-05-10 | Osteotech, Inc. | Bone matrix compositions and methods |
| WO2008157495A2 (en) | 2007-06-15 | 2008-12-24 | Osteotech, Inc. | Bone matrix compositions and methods |
| US9554920B2 (en) | 2007-06-15 | 2017-01-31 | Warsaw Orthopedic, Inc. | Bone matrix compositions having nanoscale textured surfaces |
| US9358113B2 (en) | 2007-07-10 | 2016-06-07 | Warsaw Orthopedic, Inc. | Delivery system |
| US9101475B2 (en) | 2009-02-12 | 2015-08-11 | Warsaw Orthopedic, Inc. | Segmented delivery system |
| FR2960781B1 (en) | 2010-06-07 | 2013-11-22 | Sanofi Pasteur | PREPARATION OF STABILIZED DRY ORAL VACCINE COMPOSED OF ATTENUATED LIVE VIRUS |
| US9421199B2 (en) | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
| WO2016172712A2 (en) | 2015-04-23 | 2016-10-27 | Sydnexis, Inc. | Ophthalmic composition |
| US11382909B2 (en) | 2014-09-05 | 2022-07-12 | Sydnexis, Inc. | Ophthalmic composition |
| WO2016196367A1 (en) | 2015-05-29 | 2016-12-08 | Sydnexis, Inc. | D2o stabilized pharmaceutical formulations |
| MA51060A (en) | 2017-12-07 | 2021-03-17 | Merck Sharp & Dohme | DENGUE VIRUS VACCINE COMPOSITION FORMULATIONS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL85312A (en) * | 1988-02-03 | 1991-08-16 | Israel State | Injectable pharmaceutical compositions having improved stability |
-
1993
- 1993-03-17 FR FR9303060A patent/FR2702660B1/en not_active Expired - Fee Related
-
1994
- 1994-03-17 AU AU62851/94A patent/AU6285194A/en not_active Abandoned
- 1994-03-17 EP EP94910435A patent/EP0689457A1/en not_active Withdrawn
- 1994-03-17 CN CN94191508A patent/CN1119414A/en active Pending
- 1994-03-17 WO PCT/FR1994/000296 patent/WO1994021298A1/en not_active Application Discontinuation
- 1994-03-17 CA CA002158140A patent/CA2158140A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0689457A1 (en) | 1996-01-03 |
| WO1994021298A1 (en) | 1994-09-29 |
| CA2158140A1 (en) | 1994-09-29 |
| FR2702660A1 (en) | 1994-09-23 |
| FR2702660B1 (en) | 1995-05-24 |
| CN1119414A (en) | 1996-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4534593A (en) | Compositions and methods for enhanced drug delivery | |
| AU5681294A (en) | Tastemasked pharmaceutical materials | |
| AU2157192A (en) | 4-aminoquinolines and pharmaceutical compositions thereof | |
| AU2087992A (en) | Pharmaceutical combination formulation | |
| IL110376A0 (en) | Pharmaceutical compositions containing ifetroban and methods for the preparation thereof | |
| AU7707194A (en) | Azole derivative and pharmaceutical composition thereof | |
| AU6418596A (en) | Compounds and pharmaceutical compositions containing them | |
| AU3716193A (en) | Pharmaceutical compositions | |
| AU6285194A (en) | Stabilised pharmaceutical compositions and methods for preparing same | |
| AU5100393A (en) | Diindolo compounds and pharmaceutical compositions containing them | |
| AU3635693A (en) | 1,4-dialkylpiperazine derivatives, method for obtaining them and pharmaceutical compositions containing them | |
| AU5643894A (en) | Novel esculetin derivatives and pharmaceutical composition | |
| AU7275894A (en) | Imidazolylalkylamine derivative and pharmaceutical composition thereof | |
| AU2392492A (en) | Pharmaceutical composition | |
| AU5847694A (en) | Chlorofluoroether compositions and preparation thereof | |
| AU6690394A (en) | Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof | |
| IL119603A0 (en) | Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same | |
| AU4756693A (en) | 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them | |
| AU2493792A (en) | Pharmaceutical preparation | |
| AU3710695A (en) | Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them | |
| AU6012990A (en) | Pharmaceutical formulation | |
| AU7318994A (en) | Thf-gamma2 analogs and pharmaceutical compositions comprising them | |
| AU4504893A (en) | Novel 10-diacetyl baccatine iii derivatives, preparation thereof and pharmaceutical compositions containing them | |
| AU2537992A (en) | Pharmaceutical compositions | |
| AU1482292A (en) | Pharmaceutical composition and process for the preparation thereof |